Press Releases

 

GW Pharmaceuticals plc Announces the Closing of its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the Nasdaq Global Market and Full Exercise of Underwriters’ Option to Purchase Additional ADSs - Offering raises $101.1 million

14 January 2014

London, UK, January 14, 2014: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeu... more